Reference Library
Covid-19 vaccines, Genetic vaccines, Peer-reviewed evidence, Vaccine safety & adverse events
Safety of J&J Ad26. COV2.S vaccine: Sisonke study
SisonkeTrialReport-J&J-3b-Safety-PlosMedicine Comments: BE WARY OF CONCLUSIONS IN HEADLINES AND ABSTRACTS. Reading the abstract of this J&J Covid-19 vaccine study among South African healthcare workers leaves one with a sense of trust and confidence. The authors claim “The single-dose Ad26.CoV2.S vaccine had an acceptable safety profile supporting the continued use of this vaccine in our setting.”